Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002
- PMID: 19920984
- PMCID: PMC2770378
- DOI: 10.2147/ppa.s4136
Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002
Abstract
The objective of this cross-sectional evaluation study was to compare data generated through prescriber assessments, and data generated from independent direct contact with opiate-dependent patients in office-based practice to evaluate buprenorphine treatment for modality of buprenorphine absorption, benzodiazepine use, and depressive symptoms. A group of buprenorphine office-based practice prescribers was selected to participate in this study. They were asked to screen for inclusion all their patients coming for a visit from February to August 2002. Once included by their prescribing physician, patients were given a series of self-administered questionnaires to be returned directly to the research staff, independently of their prescriber. Each prescriber was given a questionnaire to complete based on their knowledge and interview of the patient. Items assessed were history of current treatment, current substance use, buprenorphine treatment related behavior (daily frequency of intake, route of administration), benzodiazepine use and existence of a major depressive episode. Prescribers and patients' questionnaires were compared. Concordance of both assessments was assessed by kappa statistics. The sensitivity and specificity as well as the positive and negative predictive values of prescriber collected information were compared to that of their patients'. There was an overall good correlation between both data sources on the procedures for buprenorphine use especially for intravenous use of buprenorphine. There were important variations: obtaining buprenorphine without a prescription or with a prescription made by another doctor, intravenous administration of buprenorphine, use of benzodiazepines, and depression were underestimated by prescribers.
Keywords: addiction; buprenorphine; concordance; general medicine; opiates; validity.
Similar articles
-
Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices.Subst Use Misuse. 2016 Jan 2;51(1):85-90. doi: 10.3109/10826084.2015.1089905. Epub 2016 Jan 15. Subst Use Misuse. 2016. PMID: 26771870
-
Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.Drug Alcohol Depend. 2009 Jan 1;99(1-3):338-44. doi: 10.1016/j.drugalcdep.2008.07.017. Epub 2008 Sep 27. Drug Alcohol Depend. 2009. PMID: 18824311
-
Buprenorphine prescribing practice trends and attitudes among New York providers.J Subst Abuse Treat. 2017 Mar;74:1-6. doi: 10.1016/j.jsat.2016.10.005. Epub 2016 Oct 29. J Subst Abuse Treat. 2017. PMID: 28132694
-
Why buprenorphine is so successful in treating opiate addiction in France.Curr Psychiatry Rep. 2007 Oct;9(5):358-64. doi: 10.1007/s11920-007-0046-2. Curr Psychiatry Rep. 2007. PMID: 17915074 Review.
-
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4. Rural Remote Health. 2015. PMID: 25651434 Review.
Cited by
-
Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.BMC Fam Pract. 2016 Mar 1;17:24. doi: 10.1186/s12875-016-0413-3. BMC Fam Pract. 2016. PMID: 26931763 Free PMC article. Clinical Trial.
References
-
- [APA] American Psychiatric Association. [DSM-IV Manuel Diagnostique et Statistique des Troubles mentaux. 4e édition. Paris: MASSON; 1996. (Version Internationale, Washington DC, 1995)
-
-
Auriacombe M. 2005. [Quoi de neuf pour le traitement de la dépendance aux opiacés en France? Quelques spéculations. Médecine et addictions. Peut-on intervenir de façon précoce et efficace?] Reynaud M, Bailly D, Venisse J (ed), Collection Médecine et Psychothérapie: pp. 207–12.
-
-
- Auriacombe M, Fatseas M, Dubernet J, et al. French field experience with buprenorphine. Am J Addict. 2004;13(Suppl 1):S17–28. - PubMed
-
- Barrau K, Thirion X, Micallef J, et al. Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction. 2001;96:1433–41. - PubMed
-
- Bertorelle V, Auriacombe M, Grabot D, et al. [Evaluation quantitative des pratiques de partage de matériel à risque de contamination infectieuse virale chez les usagers d’opiacés par voie intraveineuse faisant une demande de soins – utilisation de l’autoquestionnaire RAB] Encephale. 2000;26:3–7. - PubMed
LinkOut - more resources
Full Text Sources